BG51042A3 - Process for the preparation of anhydrous, crystalline sodium salt of 5- chloro- 3(2- thenoyl)- 2- axindole- 1- carboxamyde - Google Patents

Process for the preparation of anhydrous, crystalline sodium salt of 5- chloro- 3(2- thenoyl)- 2- axindole- 1- carboxamyde

Info

Publication number
BG51042A3
BG51042A3 BG82816A BG8281688A BG51042A3 BG 51042 A3 BG51042 A3 BG 51042A3 BG 82816 A BG82816 A BG 82816A BG 8281688 A BG8281688 A BG 8281688A BG 51042 A3 BG51042 A3 BG 51042A3
Authority
BG
Bulgaria
Prior art keywords
carboxamyde
axindole
thenoyl
chloro
anhydrous
Prior art date
Application number
BG82816A
Other languages
English (en)
Inventor
Douglas J Allen
Brian T O'neill
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of BG51042A3 publication Critical patent/BG51042A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG82816A 1987-02-02 1988-02-01 Process for the preparation of anhydrous, crystalline sodium salt of 5- chloro- 3(2- thenoyl)- 2- axindole- 1- carboxamyde BG51042A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
BG51042A3 true BG51042A3 (en) 1993-01-15

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
BG82816A BG51042A3 (en) 1987-02-02 1988-02-01 Process for the preparation of anhydrous, crystalline sodium salt of 5- chloro- 3(2- thenoyl)- 2- axindole- 1- carboxamyde

Country Status (42)

Country Link
US (1) US5036099A (es)
EP (1) EP0277738B1 (es)
JP (1) JPS63201184A (es)
KR (1) KR900001422B1 (es)
CN (1) CN1022324C (es)
AP (1) AP52A (es)
AR (1) AR243182A1 (es)
AT (1) ATE73800T1 (es)
AU (1) AU587736B2 (es)
BG (1) BG51042A3 (es)
CA (1) CA1335590C (es)
CS (2) CS265250B2 (es)
CY (1) CY1775A (es)
DD (1) DD267490A5 (es)
DE (1) DE3869149D1 (es)
DK (1) DK44888A (es)
EC (1) ECSP941082A (es)
ES (1) ES2032955T3 (es)
FI (1) FI89598C (es)
GR (1) GR3004200T3 (es)
HK (1) HK132695A (es)
IE (1) IE60000B1 (es)
IL (1) IL85277A (es)
IN (1) IN171799B (es)
IS (1) IS1533B (es)
LV (1) LV10252B (es)
MA (1) MA21171A1 (es)
MY (1) MY102737A (es)
NO (1) NO170581C (es)
NZ (1) NZ223373A (es)
OA (1) OA08710A (es)
PH (1) PH26545A (es)
PL (1) PL149550B1 (es)
PT (1) PT86675B (es)
RO (1) RO105052B1 (es)
RU (1) RU2011381C1 (es)
SG (1) SG27994G (es)
SI (1) SI8810183A8 (es)
UA (1) UA25898A1 (es)
WO (1) WO1988005656A1 (es)
YU (1) YU46766B (es)
ZA (1) ZA88679B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
HU208421B (en) * 1988-10-18 1993-10-28 Pfizer Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity
DE68923673T2 (de) * 1988-10-18 1996-01-18 Pfizer Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
WO1997022605A1 (en) * 1995-12-19 1997-06-26 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) * 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US11653929B2 (en) 2017-11-02 2023-05-23 Accurate Medical Therapeutics Ltd. Embolization catheter with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3582890D1 (de) * 1984-02-07 1991-06-20 Pfizer 2-oxindolzwischenprodukte.
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
PT80116B (pt) * 1984-03-19 1987-10-20 Pfizer Processo para a producao de 2-oxindole-1-carboxamidas e de intermediarios para esse efeito
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
EP0277738A1 (en) 1988-08-10
IN171799B (es) 1993-01-09
AP8800081A0 (en) 1987-11-01
OA08710A (fr) 1989-03-31
CS354191A3 (en) 1992-04-15
CY1775A (en) 1996-04-05
CS64888A2 (en) 1988-08-16
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
ZA88679B (en) 1989-09-27
PT86675A (pt) 1988-03-01
IS1533B (is) 1994-01-28
CS265250B2 (en) 1989-10-13
AR243182A1 (es) 1993-07-30
UA25898A1 (uk) 1999-02-26
IE880269L (en) 1988-08-02
NO170581B (no) 1992-07-27
GR3004200T3 (es) 1993-03-31
PL149550B1 (en) 1990-02-28
FI89598B (fi) 1993-07-15
WO1988005656A1 (en) 1988-08-11
KR900001422B1 (ko) 1990-03-09
CA1335590C (en) 1995-05-16
FI89598C (fi) 1993-10-25
DK44888A (da) 1988-08-03
ES2032955T3 (es) 1996-07-16
KR880009961A (ko) 1988-10-06
AU1116088A (en) 1988-08-04
US5036099A (en) 1991-07-30
CN88100555A (zh) 1988-08-17
YU18388A (en) 1989-10-31
NO884329D0 (no) 1988-09-29
AP52A (en) 1989-09-16
JPH0576945B2 (es) 1993-10-25
PL270415A1 (en) 1988-12-08
NO170581C (no) 1992-11-04
CN1022324C (zh) 1993-10-06
ECSP941082A (es) 1994-12-15
IE60000B1 (en) 1994-05-18
DE3869149D1 (de) 1992-04-23
FI893647A0 (fi) 1989-08-01
NO884329L (no) 1988-09-29
IL85277A0 (en) 1988-07-31
PT86675B (pt) 1992-07-31
AU587736B2 (en) 1989-08-24
DK44888D0 (da) 1988-01-29
PH26545A (en) 1992-08-19
EP0277738B1 (en) 1992-03-18
RO105052B1 (en) 1994-12-01
SI8810183A8 (sl) 1996-08-31
RU2011381C1 (ru) 1994-04-30
MA21171A1 (fr) 1988-10-01
MY102737A (en) 1992-09-30
NZ223373A (en) 1989-06-28
IS3309A7 (is) 1988-08-03
IL85277A (en) 1994-02-27
ATE73800T1 (de) 1992-04-15
HK132695A (en) 1995-09-01
SG27994G (en) 1994-10-14
DD267490A5 (de) 1989-05-03
LV10252A (lv) 1994-10-20
YU46766B (sh) 1994-05-10

Similar Documents

Publication Publication Date Title
BG51042A3 (en) Process for the preparation of anhydrous, crystalline sodium salt of 5- chloro- 3(2- thenoyl)- 2- axindole- 1- carboxamyde
FR2601014B1 (fr) Hydrate cristallin de cephalosporine orale, sa composition et son procede de preparation
AU2301988A (en) Process for preparing sulfonylurea salts
FI851463L (fi) Kiinteän, kiteisen nedokromiilinatriumin valmistusmenetelmä
GB8910534D0 (en) Sodium removal from brines
EP0319767A3 (en) Process for the preparation of trifluoromethane sulfonique acid chloride
GR3017917T3 (en) Crystalline addition salts of cephem compounds and process for their preparation.
PL246090A1 (en) Process for preparing highly crystalline sodium cephoperazone
HUT46883A (en) Process for producing stable, crystalline sodium acetylsalicylate
PL243006A1 (en) Process for preparing crystalline sodium cyphoperazone
PT82343A (en) Process for preparing crystalline anhydrous sodium 19-deoxyaglycone dianemycin
PL285899A1 (en) Method of obtaining sodium salt of penicillanic acid 1,1-dioxide
CS150688A1 (en) Process for preparing sodium salt of 1-amino-4-bromantraquinon-2-sulphonic acid
CS299687A1 (en) Process for preparing active sodium carbonate
PL272875A3 (en) Method of obtaining pure sodium salt of 2-/2,6-dichloroanillin/-phenylacetic acid
BG47572A1 (en) Method for preparing of sodium salt of o- formylcephamandol
EG18479A (en) Process for preparing anhydrous crystalling sodium salt of 5-chloro-3-(2-thenoyl)-2 oxindole-1 carboxamide
PL265290A1 (en) Method of obtaining sodium hydroxide by ammonia process
CS819486A3 (en) Process for preparing anhydrous sodium sulfate
BG42250A1 (en) Method for preparing sodium salt of alpha- naphthyl- phtalaminic acid
IE860907L (en) Crystalline anydrous sodium 19-deoxyaglycone
IE870467L (en) Sodium salt of 2-nitro-1, 3-propanediol
PL276865A1 (en) Preparation method for sodium salt of the 7/z-2-(aminetiazolile-4)2-metoxyiminoacetylamine/-cephalospornic acid
IE862740L (en) Process for anhydrous salts of trifluoroacetic acid.